Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Paraca, Oct-Dec (1Q) Ordinary Profit Decreases by 1%
4809 Paraca Inc. 【J-GAAP】
Earnings ReportParaca Inc. <4809> [TSE Prime] announced its financial results after the market closed on February 6th (15:30). The ordinary profit (non-consolidated) for the first quarter of the fiscal year ending September 2026 (October to December) was 0.77 billion yen, a 1.3% decrease compared to the same period last year. Progress toward the plan for the six months ending March (first half) of 1.45 billion yen was 53.4%, below the five-year average of 58.5%.
In the most recent three-month period, from October to December (1Q), the operating profit margin decreased from 19.4% in the same period last year to 18.7%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2023 | 3,976 | 781 | 728 | 485 | 48.5 | 56.0 | Feb 7, 2024 | J-GAAP |
| Oct - Dec, 2024 | 4,410 | 855 | 785 | 534 | 53.1 | 55.4 | Feb 7, 2025 | J-GAAP |
| Oct - Dec, 2025 | 4,637 | 867 | 775 | 534 | 52.8 | 53.4 | Feb 6, 2026 | J-GAAP |
| YoY | +5.1% | +1.4% | -1.3% | 0.0% | -0.6% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 8,636 | 1,563 | 1,417 | 958 | 95.2 | 0 | May 9, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 9,100 | 1,630 | 1,450 | 990 | 98.1 | 0 | Nov 7, 2025 | J-GAAP |
| YoY | +5.4% | +4.3% | +2.3% | +3.3% | +3.1% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2024 | 16,380 | 3,021 | 2,776 | 1,817 | 181.0 | 64 | Nov 8, 2024 | J-GAAP |
| Sep, 2025 | 17,630 | 3,266 | 2,949 | 2,044 | 202.4 | 67 | Nov 7, 2025 | J-GAAP |
| Sep, 2026 Guidance | 18,600 | 3,430 | 3,040 | 2,090 | 207.1 | 70 | Nov 7, 2025 | J-GAAP |
| YoY | +5.5% | +5.0% | +3.1% | +2.3% | +2.4% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 4,410 | 855 | 785 | 534 | 53.1 | 19.4 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 4,226 | 708 | 632 | 424 | 42.1 | 16.8 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 4,423 | 786 | 704 | 472 | 46.8 | 17.8 | Aug 7, 2025 | J-GAAP |
| Jul - Sep, 2025 | 4,571 | 917 | 828 | 614 | 60.8 | 20.1 | Nov 7, 2025 | J-GAAP |
| Oct - Dec, 2025 | 4,637 | 867 | 775 | 534 | 52.8 | 18.7 | Feb 6, 2026 | J-GAAP |
| YoY | +5.1% | +1.4% | -1.3% | 0.0% | -0.6% |
Related Articles
TAKAMISAWA, First Half Ordinary Profit Decreases by 28%, Oct-Dec Ordinary Profit Decreases by 17%
SAPPORO CLINICAL LAB, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5%, Oct-Dec Ordinary Profit Decreases by 9%
SEKI, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 42%
CL Holdings, Net Income Forecast for Last Fiscal Year Revised Upward by 12%, Dividend Revised Upward by 2 Yen
MT GENEX, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 25%, Oct-Dec Ordinary Profit Increases by 93%
CMK, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 20%
KAKEN PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 96%, Oct-Dec Ordinary Profit Decreases by 91%
TAIYO YUDEN, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 47%
HARIMA B.STEM, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 17%
ASAHIPEN, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 23%, Oct-Dec Ordinary Profit Decreases by 8%